Revised German Cannabis Monograph
Recommendation

Thursday, 29 October 2026 9 .00 - 17.15 h
AI/ML-based Methods for Optimizing Pharmaceutical Research Processes
A revised German Cannabis Flower Monograph has been announced to be published in the German Pharmacopoeia (Deutsches Arzneibuch, DAB). The announcement by the German Federal Institute for Drugs and Medical Devices (BfArM) dated 26 April 2024 was published in the Federal Gazette ("Bundesanzeiger") on 14 May 2024.
The revison relates to the correction of the wording for the content calculation (formula) in the assay of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) resulting from the content of the corresponding acids.
The amended and revised German Pharmacopoeia will be valid from 1 October 2024. The new version is called ‘Deutsches Arzneibuch 2024 (DAB 2024)’ and can be obtained from the German publisher "Deutscher Apotheker Verlag".
The European Pharmacopoeia (Ph. Eur.) meanwhile contains an official Cannabis Flower monograph, which will be implemented on 1 July 2024. It is expected that the German Cannabis Flower monograph will be removed from the DAB once a valid official German translation of the Ph. Eur. Cannabis Flower monograph becomes available.
Related GMP News
29.09.2026FDA wants to Advance the Development of Herbal Medicinal Products
29.09.2026Ph. Eur. Draft for Comment: 2.8.18. Determination of Aflatoxin B1 in Herbal Drugs
29.09.2026Can Cannabis Flowers be pre-dried in Accordance with GACP?
29.09.2026Water Determination in Herbal Drugs
10.09.2026New Information Sheet regarding Cannabis for Medical Purposes
10.09.2026EMA Reflection Paper on Safety Signals for Herbal Medicinal Products


